로딩 중…
지수 로딩 중…
Pulse Biosciences, Inc.
PLSE· NASDAQ· Health Care· Health Care Equipment & Services
$37.73+7.40%
2026-08-03
Financials
Valuation Metrics
Pulse Biosciences, Inc.'s Market Cap is $2.61B. At end of 2025 it was $925M. Ranked #1880 of 3,112 in US market (top 60%), #691 of 1,445 on NASDAQ (top 48%), #107 of 206 in Health Care Equipment & Services (top 52%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.61B | US#1,880/3,112 Sec#107/206 |
| Revenue | $751000.00 | US#2,965/3,112 Sec#206/206 |
| Net Income | $-75M | US—/3,112 Sec—/206 |
| Total Assets | $82M | US#3,044/3,112 Sec#206/206 |
| Net Assets | $66M | US#2,917/3,112 Sec#194/206 |
| Value | ||
| P/B | 39.39x | US#2,910/3,112 Sec#199/206 |
| P/S | 7460.81x | US#2,960/3,112 Sec#207/206 |
| FCF Yield | -2.13% | US—/3,112 Sec—/206 |
| Profitability | ||
| ROE | -112.47% | US#2,864/3,112 Sec#184/206 |
| ROA | -91.36% | US#3,042/3,112 Sec#208/206 |
| Op. Margin | -10392.14% | US#2,959/3,112 Sec#206/206 |
| Financial Health | ||
| Debt Ratio | 23.11% | US#248/3,112 Sec#27/206 |
| Total Debt | $7M | US#2,815/3,112 Sec#190/206 |
| FCF | $-55M | US#2,479/3,112 Sec#182/206 |
| Cash | $68M | US#2,429/3,112 Sec#155/206 |
| Current Ratio | 7.26x | US#327/3,112 Sec#21/206 |
| Performance | ||
| 1Y Return | 155.80% | US#161/3,112 Sec#14/206 |
| 1M Return | 29.17% | US#48/3,112 Sec#10/206 |
| From 52W High | -1.46% | US#151/3,112 Sec#6/206 |
| 1Y MDD | -36.51% | US#1,778/3,112 Sec#90/206 |
| Trading | ||
| Volume | 345,992 shares | US#2,329/3,112 Sec#171/206 |
| Trading Value | $13M | US#2,216/3,112 Sec#151/206 |
| Per Share | ||
| EPS | $-1.08 | US—/3,112 Sec—/206 |
| BPS | $1.20 | US#2,598/3,112 Sec#178/206 |